Stanley Adkins
Internal Medicine · Indianapolis, INNPI 1972609493
Payments from drug & device makers
Across 454 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$817
- Boehringer Ingelheim$612
- Amgen$611
- Amarin Pharma, Inc.$545
- Antares Pharma, Inc.$532
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,328100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $1,130 |
| AbbVie(2 entities) | 70 | $817 |
| Boehringer Ingelheim | 31 | $612 |
| Amgen(2 entities) | 26 | $611 |
| Amarin Pharma, Inc. | 32 | $545 |
| Antares Pharma, Inc. | 24 | $532 |
| GSK | 35 | $442 |
| Lilly USA, LLC | 17 | $427 |
| AstraZeneca | 19 | $371 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $277 |
| Paratek Pharmaceuticals, Inc. | 7 | $198 |
| Kowa Pharmaceuticals America, Inc. | 14 | $174 |
| Johnson & Johnson(2 entities) | 12 | $169 |
| Merck | 10 | $140 |
| Nestle Healthcare Nutrition Inc. | 8 | $136 |
| Novartis | 8 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $81 |
| Pfizer | 5 | $72 |
| Biogen | 5 | $70 |
| Clarus Therapeutics Inc. | 6 | $66 |
| Tactile Systems Technology Inc | 1 | $47 |
| Esperion Therapeutics, Inc. | 3 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Eisai Inc. | 2 | $27 |
| Alfasigma USA, Inc. | 2 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Shield Therapeutics Inc | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Impulse Dynamics (USA) Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,345 in reported general payments places this provider in the 90th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 18 | $328 |
| Ezetimibe | 18 | $280 |
| Metoprolol Succinate | 19 | $239 |
| Tamsulosin Hcl | 12 | $194 |
| Rosuvastatin Calcium | 17 | $193 |
| Allopurinol | 11 | $166 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $137 |
| Lisinopril | 17 | $112 |
| Amlodipine Besylate | 11 | $92 |
| Atorvastatin Calcium | 17 | $64 |
| Simvastatin | 15 | $32 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Indianapolis
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- Georgiann LinnemeierIndianapolis$692K
- Allon FriedmanIndianapolis$524K
- Eromonsele IdahosaIndianapolis$471K
- Misty ShieldsIndianapolis$411K
- Pei LuIndianapolis$298K
- Paul DexterIndianapolis$161K
- Jon DukeIndianapolis$138K
- Napoleon MamintaIndianapolis$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.